Emerald Acquisition’s Sagent Pharmaceuticals SGNT Stock Holding History
Bought
Maintained
Sold
Emerald Acquisition's SGNT Position: Q3 2016 in Review
Emerald Acquisition sold out of Sagent Pharmaceuticals (SGNT) in Q3 2016, closing a stake of 524,293 shares — an estimated $7.85M sold.
Emerald Acquisition first reported a position in SGNT in Q2 2016 and held it in 1 quarter. The position peaked at $7.85M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.
- Emerald Acquisition reported no remaining Sagent Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
- Emerald Acquisition sold 524,293 Sagent Pharmaceuticals shares in Q3 2016, an estimated $7.85M.
- Emerald Acquisition first reported a position in Sagent Pharmaceuticals in Q2 2016 and held it in 1 quarter.
- Emerald Acquisition's Sagent Pharmaceuticals position peaked at $7.85M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Sagent Pharmaceuticals as of Q3 2016.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.